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Abstract
In February 1996, the genome community met in Bermuda to formulate principles for circulating genomic data. Although it
is now 20 years since the Bermuda Principles were formulated, they continue to play a central role in shaping genomic and
data-sharing practices. However, since 1996, “openness” has become an increasingly complex issue. This commentary
seeks to articulate three core challenges data-sharing faces today.
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Background
In February 1996, leaders in genome science convened in
Bermuda and penned principles for circulating genomic data
that endure today [1]. The story of the Bermuda Principles and
the commitment to daily sharing of DNA sequences prior to
publication has become one of the dominant narratives of the
Human Genome Project (HGP). Motivated in part by an attempt
to keep the human genome sequence in the public domain,
the Bermuda Principles inaugurated a commitment to openness
at the heart of the new field of genomics [Fig 1]. Since 1996,
however, the issues surrounding “openness” have become in-
creasingly complex, raising new questions about the meaning
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Fig. 1 Three “Bermuda Meetings” were held in 1996a, 1997b, and 1998c. At each subsequent meeting the principles for data sharing were affirmed, extended, updated,
and refined.
of openness itself, and how and why it should be enacted and
enforced.
Two decades after the meeting in Bermuda, on November 18,
2015, some original members of the Bermuda meetings, along
with other genome scientists and social scientists, gathered at
University of California Santa Cruz to reflect on what ‘open ge-
nomics’ means in the context of the post-HGP conditions: the
exponential growth of genomic data, the centrality of private
funding, and commitment to the right of privacy [2]. The hypoth-
esis at Santa Cruz was that revisiting the historic Bermuda Prin-
ciples would clarify what is at stake in today’s decisions about
how and whether to share data, with whom, and on what plat-
forms. The participants articulated three core challenges that
suggest ways to frame the ethical, political, and technical dilem-
mas that lie ahead.
Challenge one: what is data?
In 1996, the ‘data’ that occupied participants’ attention were the
nucleotide sequences needed to create a single human refer-
ence sequence. Today, however, the forms of relevant data are
proliferating, creating new puzzles for clinicians, genome scien-
tists, epidemiologists, and potential patients and research par-
ticipants. We have expanded our capabilities from analyzing
and interpreting one individual’s data to exponential numbers
of people and exponential amounts of data. These derive not
just from sequences, but also from other ‘omics’ data, such as
metabolomics,metagenomics, proteomics, epigenomics and ex-
posomics, which is now increasingly linked to socio-economic,
behavioral, genealogical, clinical, and GIS data. Despitemanifest
differences between different types of data, the Bermuda Princi-
ples are often invoked as a touchstone for the “right” approach
to use and reuse.
However, the uses and value of these data - and proper struc-
tures for their governance - are often far from clear. Practitioners
within different subfields collect, process, clean, report, and an-
alyze data in different ways. What counts as data thus often de-
pends on specific disciplinary norms, standards, and modes of
valuation. Data collected via automated, high-throughput tech-
niques may be valued differently by experimenters, publishers
and regulators than curated data or data coded through long-
term fieldwork.
Furthermore, practices for creating valuable data in small
communities often differ from those in very large ones. Before
and during the early phases of the HGP, model organism com-
munities (in particular, those studying Caenorhabditis elegans and
Drosophila) developed varied norms and practices for collecting,
curating, and communicating data. At Santa Cruz, Jenny Bang-
ham, Robert Kuhn, and Bob Waterston discussed some early
tools used for sharing information and assigning credit, such as
the newsletters Drosophila Information Service and The Worm
Breeder’s Gazette [3]. Even in such close-knit communities, pre-
publication ‘sharing’ occurred within carefully managed net-
works and systems of trust and credit [Fig. 2].
Today genomic data are no longer created solely within the
confines ofmodel organism communities. Rather, data are often
donated by individuals with interests in how they are used. How
then do scientistsmake decisions about data’s value when there
is no community to ensure quality control (e.g., for species that
are not model organisms)? Without the guidance of community
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Fig. 2 Covers of biology community newsletters; here, Arabidopsis Newsletter (1990) and Worm Breeder’s Gazette (1990). These, like Drosophila Information Service and
many others (see [3] for a partial list), helped to adjudicate community membership and mediate sharing and ownership. They typically communicated technical
innovations, nomenclatures, community news and lists of which (living) stocks could be obtained from what laboratories. Cover images courtesy of Department of
Genetics Library, University of Cambridge.
norms, how should we decide when data are good enough to
share?
Challenge two: what is sharing?
Alongside new criteria and practices for creating valuable data,
we require new standards and practices for sharing. When the
HGP began in the early 1990s, its funders decided that scien-
tists needed to share the incomplete data they produced; but,
more precisely what needed to be shared, with whom, when
and how was a matter of debate. These were the problems that
the Bermuda meetings (including those in 1997 and 1998) at-
tempted to address. The enduring challenge today is that ‘shar-
ing’ is value-heavy, but conceptually thin. Sharing is an almost
universally embraced value. The concept of sharing, however,
does not capture the technical complexity or specificity of what
it means to deposit, store, transfer, exchange, transport, or in-
terconnect genomic data and health information in a digitally
networked world [4].
Clarifying the goals of data sharing is harder today than it
was twodecades ago.Making large amounts of datawidely avail-
able for a long period of time and re-usable by third-parties in-
volves substantial human and infrastructural resources. Who
will support the storage, upload, curation and publication of ever
expanding quantities of data? And who will ensure the privacy
and interests of patients and research participants? What are
the promises and limits of technical solutions? What methods
will engender trust? And how will credit be allocated?
In Santa Cruz, Stephen Hilgartner called for greater nuance
in how we describe the governance of data throughout the
process of producing, collecting, and exchanging them, both
before and after publication. He suggested conceptualizing vari-
ous “data regimes” for guiding projects in biomedicine [5]. Data,
he argued, exist within governing structures that delineate the
roles of funders, scientists, laboratories, universities, data stor-
age infrastructure, algorithms, medical industries, human sub-
jects, and institutional review boards. Each of these entities is
endowed with rights, responsibilities, and privileges for access-
ing and controlling data. Describing such rights and responsi-
bilities explicitly will help us to clarify the goals, tradeoffs, and
beneficiaries of data sharing.
Challenge three: what is a public good?
It may seem that the Bermuda Principles presented a clear vi-
sion of the public good: open data shared immediately with the
scientific community. Bermuda embraced the idea that the HGP
sequence data were a self-evident public good. Yet, at the Santa
Cruz meeting Kathryn Maxson and Rachel Ankeny offered an
analysis of the Bermuda meetings showing that the issues were
not clear cut [6]. Bermuda participants from European coun-
tries and Japan raised concerns that a 24-hour release would im-
pede the ability of government-funded scientists to make good
on their research investments through patents. For them, pri-
vate pharmaceutical development represented a public good.
Many at the Bermudameetings—not just those from Europe and
Japan—viewed open data and commercial products as mutu-
ally reinforcing. Indeed, recent economic analyses show how
genomic sequences in the public domain spurred more com-
mercialization and for-profit drug development than did the re-
stricted data from Craig Venter’s Celera Genomics [7].
Today, as universities, governments and companies collabo-
rate and compete to create the platforms thatmake data flow,we
can no longer rely on a simplistic distinction between public and
private to conceptualize good data governance. Acquiring the
ever-escalating resources needed for generating data leads sci-
entists to seek funding from varied sources. Indeed, large sums
of money often no longer raise suspicions, but garner esteem.
If we can no longer rely on the public/private boundary to de-
lineate good approaches to sharing data, we are left with a final
pressing puzzle: how do we ensure that data leads to knowledge
and the public good?
Many of the tests and treatments arising from genomic data
have to date been extremely expensive and have not seen wide
clinical utility [8]. How do we ensure equitable distribution of
the benefits? While genomics cannot solve the ‘social ills’ of
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healthcare systems, data governance cannot ignore the fact that
today’s -omic data are collected and usedwithin inequitable and
fragmented healthcare infrastructures, particularly in the US [9].
A policy of open data will not guarantee that everyone has equal
access or benefits.We thus face the challenge of creating not just
an open, but also a just approach to sharing biomedical data [10].
Toward ‘Good’ genomic science
The moral grounds that solidified during the HGP, complex as
they were, no longer provide adequate guidance. At Santa Cruz,
we updated the received views about the Bermuda Meetings,
transforming the principles of 1996 into key challenges for 2016
and beyond. The Santa Cruz challenges show us that we need
a better understanding of the actual practices and stakes in-
volved in data sharing. We must clarify what we mean when
we talk about genomic data and “the public good.” Understand-
ing how value is created through specific flows of data will lay
the groundwork for more engaged deliberations about the ben-
efits and drawbacks of various sharing regimes. Developing ro-
bust agreements about data governance in the postgenomic era
requires creating experimental spaces and cross-disciplinary di-
alogues such as those at Santa Cruz.
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Endnotes
A) The 1996 Bermuda Meeting Report can be found at http://
hdl.handle.net/10161/7715, B) The 1997 Bermuda Meeting Re-
port can be found at http://hdl.handle.net/10161/7733 and C)
The 1998 Bermuda Report can be found at http://hdl.handle.net/
10161/7745.
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